Idiopathic pulmonary fibrosis (IPF) is a chronic inflammatory disease characterized by progressive scarring (fibrosis) of the lung tissue, with a consequent decrease in its functionality that will gradually trigger respiratory failure associated with poor prognosis.
Idiopathic pulmonary fibrosis
Although the exact causes of IPF are unknown, it is known that multiple genetic and environmental factors are involved in its development. Having a family history of pulmonary fibrosis is an important risk factor, but other factors also play a role:
- Age, it usually appears from 60 years of age onwards
- Sex, it is more frequent in men than in women.
- Exposure to antigens known to cause hypersensitivity pneumonitis (lung inflammation).
- Environmental and occupational exposure to inhaled particles such as tobacco smoke, asbestos, metal and wood dust.
Symptoms
Prevention
There is currently no effective treatment available to cure IPF, recommendations to prevent IPF focus on minimizing associated modifiable risk factors that may favor its onset and worsen symptoms. It is recommended:
- Do not smoke or expose yourself to tobacco smoke.
- Exercise regularly. In people with IPF it has been observed that breathing exercises can help improve lung function.
- Maintain a healthy and balanced diet.
- Follow the recommended guidelines for vaccination against respiratory infections and prevent infection by these as far as possible.
Number of observed variants
13.5 million variants
Number of loci analyzed
13 loci
Genes analyzed
Bibliography
Allen RJ, Guillen-Guio B, Oldham JM, et al. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 Mar 1;201(5):564-574.
Podolanczuk AJ, Thomson CC, Remy-Jardin M, et al. Idiopathic pulmonary fibrosis: state of the art for 2023. Eur Respir J. 2023 Apr 20;61(4):2200957.
Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017 May 13;389(10082):1941-1952.
